所有产品
  • 抗体
  • 试剂盒
  • 多肽
  • 探针
  • 蛋白
  • 生化试剂
  • 组织芯片
EN
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
乳腺
当前位置：首页 > 组织芯片 > 乳腺 > 乳腺
组织芯片
乳腺癌，75例，150芯（1.1mm），系列4
  • 货号： BRC1504
  • 芯片名称： 乳腺癌，75例，150芯（1.1mm），系列4
  • 芯片描述： 乳腺癌组织芯片，系列4，Non不与BRC1501，BRC1502，BRC1503，BRC1505 到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
定制服务咨询
详细相关信息
武汉天德生物病理生物芯片系列-BRC1504      
芯片编号 BRC1504
芯片名称 乳腺癌，75例，150芯（1.1mm），系列4
芯片说明 乳腺癌组织芯片，系列4，Non不与BRC1501，BRC1502，BRC1503，BRC1505 到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
点数: 150芯
例数: 75例
组织固定方式: 福尔马林固定24h
QA/QC: HE染色和IHC染色
应用: 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH)，可以在我们的技术支持页面找到操作流程。
注意事项: 1.收到产品后请常温保存，并在24个月内使用，2.请在实验前60°烤片30分钟，3.请选择温和的修复方式，以免造成组织脱落。
                         
Array Name Array Position Order Age Sex Anatomic Site Pathology Nature Grade Stage (TNM) Intensity Percent Comment
BRC1504 A01 1 44 F Breast Normal Normal 　 　 1 5% 　
BRC1504 A02 2 45 F Breast Fibrocystic changes Benign 　 　 1 5% 　
BRC1504 A03 3 45 F Breast Fibrocystic changes Benign 　 　 1 5% 　
BRC1504 A04 4 42 F Breast Fibrocystic changes Benign 　 　 0.5 　 　
BRC1504 A05 5 58 F Breast Fibrocystic changes Benign 　 　 0.5 　 　
BRC1504 A06 6 42 F Breast Invasive ductal carcinoma Malignant III T2N0M0 1 5% 　
BRC1504 A07 7 37 F Breast Invasive ductal carcinoma Malignant III T2N0M0 0 　 　
BRC1504 A08 8 39 F Breast Invasive ductal carcinoma Malignant I T4N1M0 0 　 　
BRC1504 A09 9 52 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 A10 10 50 F Breast Invasive ductal carcinoma Malignant III T2N1M0 1 5% 　
BRC1504 A11 11 38 F Breast Invasive ductal carcinoma Malignant III T2N1M0 0 　 　
BRC1504 A12 12 34 F Breast Invasive ductal carcinoma Malignant II T2N1M0 1 5% 　
BRC1504 A13 13 62 F Breast Ductal carcinoma in situ Malignant I TisN0M0 1 5% 　
BRC1504 A14 14 33 F Breast Invasive ductal carcinoma Malignant I T3N1M0 1 5% 　
BRC1504 A15 15 36 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 B01 16 44 F Breast Normal Normal 　 　 1 5% 　
BRC1504 B02 17 45 F Breast Fibrocystic changes Benign 　 　 1 5% 　
BRC1504 B03 18 45 F Breast Fibrocystic changes Benign 　 　 1 5% 　
BRC1504 B04 19 42 F Breast Fibrocystic changes Benign 　 　 0.5 　 　
BRC1504 B05 20 58 F Breast Fibrocystic changes Benign 　 　 0.5 　 　
BRC1504 B06 21 42 F Breast Invasive ductal carcinoma Malignant III T2N0M0 1 5% 　
BRC1504 B07 22 37 F Breast Invasive ductal carcinoma Malignant III T2N0M0 0 　 　
BRC1504 B08 23 39 F Breast Invasive ductal carcinoma Malignant I T4N1M0 0 　 　
BRC1504 B09 24 52 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 B10 25 50 F Breast Invasive ductal carcinoma Malignant III T2N1M0 1 5% 　
BRC1504 B11 26 38 F Breast Invasive ductal carcinoma Malignant III T2N1M0 0 　 　
BRC1504 B12 27 34 F Breast Invasive ductal carcinoma Malignant II T2N1M0 1 5% 　
BRC1504 B13 28 62 F Breast Ductal carcinoma in situ Malignant I TisN0M0 1 5% 　
BRC1504 B14 29 33 F Breast Invasive ductal carcinoma Malignant I T3N1M0 1 5% 　
BRC1504 B15 30 36 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 C01 31 34 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0.5 　 　
BRC1504 C02 32 57 F Breast Invasive ductal carcinoma Malignant II T1N0M0 3 60% 　
BRC1504 C03 33 46 F Breast Invasive ductal carcinoma Malignant III T2N0M0 1 5% 　
BRC1504 C04 34 52 F Breast Invasive ductal carcinoma Malignant III T2N1M0 2 20% 　
BRC1504 C05 35 44 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 C06 36 44 F Breast Mucinous adenocarcinoma Malignant 　 T2N0M0 1 5% 　
BRC1504 C07 37 37 F Breast Invasive ductal carcinoma Malignant I T2N0M0 1 5% 　
BRC1504 C08 38 27 F Breast Invasive ductal carcinoma Malignant III T2N0M0 1 5% 　
BRC1504 C09 39 32 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 C10 40 55 F Breast Invasive ductal carcinoma Malignant II T3N3M0 0 　 　
BRC1504 C11 41 60 F Breast Invasive ductal carcinoma Malignant II T3N0M0 1 8% 　
BRC1504 C12 42 52 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 C13 43 56 F Breast Ductal carcinoma in situ Malignant I TisN1M0 1 8% 　
BRC1504 C14 44 30 F Breast Invasive lobular carcinoma Malignant II T2N1M0 1 8% 　
BRC1504 C15 45 43 F Breast Invasive ductal carcinoma Malignant III T2N1M0 0 　 　
BRC1504 D01 46 34 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0.5 　 　
BRC1504 D02 47 57 F Breast Invasive ductal carcinoma Malignant II T1N0M0 3 60% 　
BRC1504 D03 48 46 F Breast Invasive ductal carcinoma Malignant III T2N0M0 1 5% 　
BRC1504 D04 49 52 F Breast Invasive ductal carcinoma Malignant III T2N1M0 2 20% 　
BRC1504 D05 50 44 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 D06 51 44 F Breast Mucinous adenocarcinoma Malignant 　 T2N0M0 1 5% 　
BRC1504 D07 52 37 F Breast Invasive ductal carcinoma Malignant I T2N0M0 1 5% 　
BRC1504 D08 53 27 F Breast Invasive ductal carcinoma Malignant III T2N0M0 1 5% 　
BRC1504 D09 54 32 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 D10 55 55 F Breast Invasive ductal carcinoma Malignant II T3N3M0 0 　 　
BRC1504 D11 56 60 F Breast Invasive ductal carcinoma Malignant II T3N0M0 1 8% 　
BRC1504 D12 57 52 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 D13 58 56 F Breast Ductal carcinoma in situ Malignant I TisN1M0 1 8% 　
BRC1504 D14 59 30 F Breast Invasive lobular carcinoma Malignant II T2N1M0 1 8% 　
BRC1504 D15 60 43 F Breast Invasive ductal carcinoma Malignant III T2N1M0 0 　 　
BRC1504 E01 61 44 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 E02 62 42 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 E03 63 57 F Breast Invasive ductal carcinoma Malignant II T1N0M0 1 8% 　
BRC1504 E04 64 54 F Breast Invasive ductal carcinoma Malignant III T3N1M0 1 8% 　
BRC1504 E05 65 46 F Breast Invasive lobular carcinoma Malignant II T2N1M0 0 　 　
BRC1504 E06 66 37 F Breast Invasive ductal carcinoma Malignant III T3N1M0 0 　 　
BRC1504 E07 67 34 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 E08 68 52 F Breast Invasive ductal carcinoma Malignant II T3N0M0 0 　 　
BRC1504 E09 69 68 F Breast Papillary adenocarcinoma Malignant I T3N0M0 0 　 　
BRC1504 E10 70 51 F Breast Invasive ductal carcinoma Malignant I T3N1M0 3 60% 　
BRC1504 E11 71 37 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 E12 72 46 F Breast Invasive ductal carcinoma Malignant I T2N0M0 0 　 　
BRC1504 E13 73 35 F Breast Invasive ductal carcinoma Malignant II T2N1M0 1 8% 　
BRC1504 E14 74 55 F Breast Invasive ductal carcinoma Malignant II T3N0M0 1 8% 　
BRC1504 E15 75 37 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 0 　 　
BRC1504 F01 76 44 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 F02 77 42 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 F03 78 57 F Breast Invasive ductal carcinoma Malignant II T1N0M0 1 8% 　
BRC1504 F04 79 54 F Breast Invasive ductal carcinoma Malignant III T3N1M0 1 8% 　
BRC1504 F05 80 46 F Breast Invasive lobular carcinoma Malignant II T2N1M0 0 　 　
BRC1504 F06 81 37 F Breast Invasive ductal carcinoma Malignant III T3N1M0 0 　 　
BRC1504 F07 82 34 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 F08 83 52 F Breast Invasive ductal carcinoma Malignant II T3N0M0 0 　 　
BRC1504 F09 84 68 F Breast Papillary adenocarcinoma Malignant I T3N0M0 0 　 　
BRC1504 F10 85 51 F Breast Invasive ductal carcinoma Malignant I T3N1M0 3 60% 　
BRC1504 F11 86 37 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 F12 87 46 F Breast Invasive ductal carcinoma Malignant I T2N0M0 0 　 　
BRC1504 F13 88 35 F Breast Invasive ductal carcinoma Malignant II T2N1M0 1 8% 　
BRC1504 F14 89 55 F Breast Invasive ductal carcinoma Malignant II T3N0M0 1 8% 　
BRC1504 F15 90 37 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 0 　 　
BRC1504 G01 91 47 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 G02 92 54 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 G03 93 57 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1504 G04 94 41 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1504 G05 95 51 F Breast Invasive ductal carcinoma Malignant III T2N0M0 0 　 　
BRC1504 G06 96 44 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1504 G07 97 70 F Breast Invasive ductal carcinoma Malignant I T2N0M0 0 　 　
BRC1504 G08 98 68 F Breast Invasive ductal carcinoma Malignant II T4N0M0 0 　 　
BRC1504 G09 99 55 F Breast Invasive ductal carcinoma Malignant III T2N1M0 0 　 　
BRC1504 G10 100 48 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 8% 　
BRC1504 G11 101 47 F Breast Invasive lobular carcinoma Malignant I T4N1M0 1 5% 　
BRC1504 G12 102 68 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 G13 103 70 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1504 G14 104 29 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 G15 105 35 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 H01 106 47 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 H02 107 54 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 H03 108 57 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1504 H04 109 41 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1504 H05 110 51 F Breast Invasive ductal carcinoma Malignant III T2N0M0 0 　 　
BRC1504 H06 111 44 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1504 H07 112 70 F Breast Invasive ductal carcinoma Malignant I T2N0M0 0 　 　
BRC1504 H08 113 68 F Breast Invasive ductal carcinoma Malignant II T4N0M0 0 　 　
BRC1504 H09 114 55 F Breast Invasive ductal carcinoma Malignant III T2N1M0 0 　 　
BRC1504 H10 115 48 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 8% 　
BRC1504 H11 116 47 F Breast Invasive lobular carcinoma Malignant I T4N1M0 1 5% 　
BRC1504 H12 117 68 F Breast Invasive ductal carcinoma Malignant II T2N1M0 0 　 　
BRC1504 H13 118 70 F Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1504 H14 119 29 F Breast Invasive ductal carcinoma Malignant III T3N0M0 0 　 　
BRC1504 H15 120 35 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 I01 121 40 F Breast Invasive ductal carcinoma Malignant II T2N0M0 2 30% 　
BRC1504 I02 122 52 F Breast Invasive lobular carcinoma Malignant II T2N1M0 0 　 　
BRC1504 I03 123 59 F Breast Invasive lobular carcinoma  Malignant I T2N0M0 1 5% 　
BRC1504 I04 124 38 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 I05 125 43 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 I06 126 21 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 I07 127 86 F Breast Invasive ductal carcinoma Malignant II T4N0M0 1 5% 　
BRC1504 I08 128 48 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0.5 　 　
BRC1504 I09 129 35 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 I10 130 53 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 I11 131 80 F Breast Invasive ductal carcinoma Malignant I~II T2N0M0 0 　 　
BRC1504 I12 132 56 F Breast Invasive lobular carcinoma Malignant I T2N1M0 0 　 　
BRC1504 I13 133 40 F Breast Invasive ductal carcinoma Malignant III T2N0M0 0 　 　
BRC1504 I14 134 44 F Breast Invasive ductal carcinoma Malignant II T3N1M0 0 　 　
BRC1504 I15 135 41 F Breast Invasive ductal carcinoma Malignant II T3N0M0 1 8% 　
BRC1504 J01 136 40 F Breast Invasive ductal carcinoma Malignant II T2N0M0 2 30% 　
BRC1504 J02 137 52 F Breast Invasive lobular carcinoma Malignant II T2N1M0 0 　 　
BRC1504 J03 138 59 F Breast Invasive lobular carcinoma  Malignant I T2N0M0 1 5% 　
BRC1504 J04 139 38 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 J05 140 43 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 J06 141 21 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 J07 142 86 F Breast Invasive ductal carcinoma Malignant II T4N0M0 1 5% 　
BRC1504 J08 143 48 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0.5 　 　
BRC1504 J09 144 35 F Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1504 J10 145 53 F Breast Ductal carcinoma in situ Malignant 　 TisN0M0 1 5% 　
BRC1504 J11 146 80 F Breast Invasive ductal carcinoma Malignant I~II T2N0M0 0 　 　
BRC1504 J12 147 56 F Breast Invasive lobular carcinoma Malignant I T2N1M0 0 　 　
BRC1504 J13 148 40 F Breast Invasive ductal carcinoma Malignant III T2N0M0 0 　 　
BRC1504 J14 149 44 F Breast Invasive ductal carcinoma Malignant II T3N1M0 0 　 　
BRC1504 J15 150 41 F Breast Invasive ductal carcinoma Malignant II T3N0M0 1 8%